Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations

Kaohsiung Journal of Medical Sciences

Volumn 29, Issue 7, 2013, Pages 385-395

  Tseng, Po Lin ^a,b   Wang, Jing Houng ^a   Hung, Chao Hung ^a   Tung, Hung Da ^c   Chen, Tsung Ming ^d   Huang, Wu Shiung ^e   Liu, Shiann Long ^f   Hu, Tsung Hui ^a   Lee, Chuan Mo ^a   Lu, Sheng Nan ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^e Wu Shiung Huang Clinic   (Taiwan)

^f Min Sheng Clinic at Lieujia Township   (Taiwan)

Author keywords

AAR to platelet ratio index (AARPRI); Hepatocellular carcinoma; Liver cirrhosis; Noninvasive indices; Platelet

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ACCURACY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; ENDEMIC DISEASE; FEMALE; GROUPS BY AGE; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD PLATELETS; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INPATIENTS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OUTPATIENTS; PLATELET COUNT; PROGNOSIS; THROMBOCYTOPENIA;

EID: 84879103393     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2012.11.007     Document Type: Article

References (40)

1. I. Merican, R. Guan, D. Amarapuka, M.J. Alexander, A. Chutaputti, and R.N. Chien Chronic hepatitis B virus infection in Asian countries J Gastroenterol Hepatol 15 2000 1356 1361
2. P. Marcellin, T. Asselah, and N. Boyer Fibrosis and disease progression in hepatitis C Hepatology 36 2002 S47 S56
3. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update of recommendations Hepatology 39 2004 857 861
4. D.B. Strader, T. Wright, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C Hepatology 39 2004 1147 1171
5. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
6. A. Regev, M. Berho, L.J. Jeffers, C. Milikowski, E.G. Molina, and N.T. Pyrsopoulos Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
7. J. Perrault, D.B. McGill, B.J. Ott, and W.F. Taylor Liver biopsy: complications in 1000 inpatients and outpatients Gastroenterology 74 1978 103 106
8. J.B. Wong, and R.S. Koff Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis Ann Intern Med 133 2000 665 675
9. E. Giannini, D. Risso, F. Botta, B. Chiarbonello, A. Fasoli, and F. Malfatti Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease Arch Intern Med 163 2003 218 224
10. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, and H.S. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
11. Y. Murawaki, M. Koda, K. Okamoto, K. Mimura, and H. Kawasaki Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C J Gastroenterol Hepatol 16 2001 777 781
12. C.T. Wai, C.L. Cheng, A. Wee, Y.Y. Dan, E. Chan, and W. Chua Non-invasive models for predicting histology in patients with chronic hepatitis B Liver Int 26 2006 666 672
13. A. Pohl, C. Behling, D. Oliver, M. Kilani, P. Monson, and T. Hassanein Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection Am J Gastroenterol 96 2001 3142 3146
14. T. Poynard, and P. Bedossa Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups J Viral Hepat 4 1997 199 208
15. E. Giannini, and R. Testa Noninvasive diagnosis of fibrosis: the truth is rarely pure and never simple Hepatology 38 2003 1312 1313
16. T. Berg, C. Sarrazin, H. Hinrichsen, P. Buggisch, T. Gerlach, and R. Zachoval Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C? Hepatology 39 2004 1456 1458
17. R.P. Myers, M.H. Tainturier, V. Ratziu, A. Piton, V. Thibault, and F. Imbert-Bismut Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B J Hepatol 39 2003 222 230
18. A.Y. Hui, H.L. Chan, V.W. Wong, C.T. Liew, A.M. Chim, and F.K. Chan Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model Am J Gastroenterol 100 2005 616 623
19. M.D. Zeng, L.G. Lu, Y.M. Mao, D.K. Qiu, J.Q. Li, and M.B. Wan Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model Hepatology 42 2005 1437 1445
20. S.A. Raza, G.M. Clifford, and S. Franceschi Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review Br J Cancer 96 2007 1127 1134
21. M.W. Yu, and C.J. Chen Hepatitis B and C viruses in the development of hepatocellular carcinoma Crit Rev Oncol Hematol 17 1994 71 91
22. G. Fattovich, T. Stroffolini, I. Zagni, and F. Donato Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 2004 S35 S50
23. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
24. S.N. Lu, J.H. Wang, S.L. Liu, C.H. Hung, C.H. Chen, and H.D. Tung Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma Cancer 107 2006 2212 2222
25. R.G. Knodell, K.G. Ishak, W.C. Black, T.S. Chen, R. Craig, and N. Kaplowitz Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
26. C.H. Hung, S.N. Lu, J.H. Wang, C.M. Lee, T.M. Chen, and H.D. Tung Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis J Gastroenterol 38 2003 153 157
27. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
28. J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
29. J.C. Peirce, and R.G. Cornell Integrating stratum-specific likelihood ratios with the analysis of ROC curves Med Decis Making 13 1993 141 151
30. Y. Kamimoto, S. Horiuchi, S. Tanase, and Y. Morino Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells Hepatology 5 1985 367 375
31. M. Okuda, K. Li, M.R. Beard, L.A. Showalter, F. Scholle, and S.M. Lemon Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein Gastroenterology 122 2002 366 375
32. B. Nalpas, A. Vassault, A. Le Guillou, B. Lesgourgues, N. Ferry, and B. Lacour Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis Hepatology 4 1984 893 896
33. M. Peck-Radosavljevic, J. Zacherl, Y.G. Meng, J. Pidlich, E. Lipinski, and F. Langle Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27 1997 127 131
34. E. Giannini, P. Borro, F. Botta, A. Fumagalli, F. Malfatti, and E. Podesta Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis J Hepatol 37 2002 572 577
35. T. Nagamine, T. Ohtuka, K. Takehara, T. Arai, H. Takagi, and M. Mori Thrombocytopenia associated with hepatitis C viral infection J Hepatol 24 1996 135 140
36. G. Bordin, M. Ballare, P. Zigrossi, M.C. Bertoncelli, L. Paccagnino, and A. Baroli A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol 13 Suppl. 13 1995 S39 S43
37. N.H. Afdhal The natural history of hepatitis C Semin Liver Dis 24 Suppl. 2 2004 3 8
38. G. Borroni, R. Ceriani, M. Cazzaniga, M. Tommasini, M. Roncalli, and C. Maltempo Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C Aliment Pharmacol Ther 24 2006 797 804
39. A. Iacobellis, A. Mangia, G. Leandro, R. Clemente, V. Festa, and V. Attino External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis Am J Gastroenterol 100 2005 868 873
40. N. Snyder, L. Gajula, S.Y. Xiao, J. Grady, B. Luxon, and D.T. Lau APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C J Clin Gastroenterol 40 2006 535 542